Group 7 Copy 3 Created with Sketch.

MENU
Centers
Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous
News Current Issue Archive Device Guide Calendar Subscribe Advertising About Contact Privacy Submissions

Advertisement

September 24, 2025

Jupiter Endovascular’s Vertex Catheter Receives FDA Clearance

September 24, 2025—Jupiter Endovascular, Inc. announced that its Vertex catheter has received FDA 510(k) clearance for the insertion of endovascular devices.

The Vertex intravascular device features the company’s Endoportal Control platform with TFX—transforming fixation—technology that allows it to shift from flexible to firm on demand for stability and control, stated the company.

Jupiter Endovascular’s announcement, which was posted on its LinkedIn media page, includes the link to the FDA database listing for the clearance.

In October 2024, the company announced the commencement of the SPIRARE II United States pivotal trial of the Vertex system with Endoportal Control for pulmonary embolectomy to treat acute pulmonary embolism in an endovascular procedure.

Advertisement

September 24, 2025

Medtronic Neurovascular Names Dr. Adam S. Arthur as Chief Medical Officer

left-arrow Created with Sketch. Previous Article

September 24, 2025

SVS Publishes Clinical Practice Guidelines on Management of Intermittent Claudication

Next Article right-arrow Created with Sketch.

Advertisement

Cardiac Interventions Today
Group 7 Copy 3 Created with Sketch.
bmc-secondary-mark-color copy Created with Sketch.

© 2026 Bryn Mawr Communications II, LLC.  
All Rights Reserved   •   Privacy Policy

one-trust-button
)